Trends in utilization of antiepileptic drugs in Denmark

Acta Neurologica Scandinavica

Volumn 113, Issue 6, 2006, Pages 405-411

  Tsiropoulos, I ^a,b   Gichangi, A ^b   Andersen, M ^b   Bjerrum, L ^b   Gaist, D ^a   Hallas, J ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Anticonvulsants; Antiepileptic drugs; Drug utilization; Epilepsy; Prescription register

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETHOTOIN; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; NEUROLEPTIC AGENT; OPIATE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DENMARK; DRUG UTILIZATION; EPILEPSY; FEMALE; HUMAN; INCIDENCE; MALE; MONOTHERAPY; MOOD DISORDER; PAIN; PRESCRIPTION; PREVALENCE;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; DENMARK; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; EPILEPSY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOOD DISORDERS; NEUROPHARMACOLOGY; PAIN, INTRACTABLE; PREVALENCE;

EID: 33745019248     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00639.x     Document Type: Article

References (28)

1. REYNOLDS EH. The ILAE/IBE/WHO Global Campaign against Epilepsy: Bringing Epilepsy Out of the Shadows'. Epilepsy Behav 2000;1:S3-8.
2. THEODORE WH, FISHER RS. Brain stimulation for epilepsy. Lancet Neurol 2004;3:111-8.
3. ENGEL J JR, WIEBE S, FRENCH J et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003;60:538-47.
4. SPINA E, PERUGI G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord 2004;6:57-75.
5. BEGHI E, MONTICELLI ML, MONZA G, SESSA A, ZARRELLI M. Antiepileptic drugs as 'tracers' of disease. A calculation of the prevalence of epilepsy through an analysis of drug consumption. The Group for the Study of Epilepsy in General Practice. Neuroepidemiology 1991;10:33-41.
6. GIULIANI G, TERZIANI S, SENIGAGLIA AR, LUCCIONI G, FOSCHI N, MAEI C. Epilepsy in an Italian community as assessed by a survey for prescriptions of antiepileptic drugs: epidemiology and patterns of care. Acta Neurol Scand 1992;85:23-31.
7. BANfi R, BORSELLI G, MARINAI C, BORGHERESI A, CAVALIERI A. Epidemiological study of epilepsy by monitoring prescriptions of antiepileptic drugs. Pharm World Sci 1995;17:138-40.
8. SHACKLETON DP, WESTENDORP RGJ, KASTELEIJN-NOLST TRENITE DGA, DE BOER A, HERINGS RMC. Dispensing epilepsy medication: a method of determining the frequency of symptomatic individuals with seizures. J Clin Epidemiol 1997;50:1061-8.
9. ROBERTS SJ, FEELY M, BATEMAN DN. Prescribing of antiepileptic drugs in the northern and Yorkshire region: 1992-1995. Seizure 1998;7:127-32.
10. ROCHAT P, HALLAS J, GAIST D, FRIIS ML. Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol Scand 2001;104:6-11.
11. HALLAS J, NISSEN A. Individualized drug utilization statistics. Analysing a population's drug use from the perspective of individual users. Eur J Clin Pharmacol 1994;47:367-72.
12. GAIST D, SORENSEN HT, HALLAS J. The Danish prescription registries. Dan Med Bull 1997;44:445-8.
13. SANDER JW, SHORVON SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996;61:433-43.
14. HAUSER WA, ANNEGERS JF, KURLAND LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.
15. COCKERELL OC, ECKLE I, GOODRIDGE DM, SANDER JW, SHORVON SD. Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry 1995;58:570-6.
16. MANTEL-TEEUWISSE AK, KLUNGEL OH, VERSCHUREN WM, PORSIUS A, DE BA. Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 2001;54:1181-6.
17. BACKONJA MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002;59:S14-7.
18. DUBINSKY RM, KABBANI H, EL CHAMI Z, BOUTWELL C, ALI H. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63:959-65.
19. CARRAZANA E, MIKOSHIBA I. Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manage 2003;25:S31-5.
20. KANIECKI RG. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Arch Neurol 1997;54:1141-5.
21. BRANDES JL, SAPER JR, DIAMOND M et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291:965-73.
22. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159:1-50.
23. FRIIS ML, KRISTENSEN O, BOAS J et al. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand 1993;87:224-7.
24. DWORKIN RH, BACKONJA M, ROWBOTHAM MC et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524-34.
25. FINNERUP NB, OTTO M, MCQUAY HJ, JENSEN TS, SINDRUP SH. Algorithm for neuropathic pain treatment: an evidence-based proposal. Pain 2005;118:289-305.
26. JARLBAEK L, ANDERSEN M, KRAGSTRUP J, HALLAS J. Cancer patients' share in a population's use of opioids. A linkage study between a prescription database and the Danish Cancer Registry. J Pain Symptom Manage 2004;27:36-43.
27. GILLIAM F, KANNER AM. Treatment of depressive disorders in epilepsy patients. Epilepsy Behav 2002;3:2-9.
28. GAITATZIS A, TRIMBLE MR, SANDER JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004;110:207-20.